Following epiq Animal Health and Interpath Global?
Get the free weekly contract digest
The latest new contracts, like epiq Animal Health and Interpath Global’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
epiq Animal Health and Interpath Global Partner to Bring Revolutionary Joint Health Product to US Market
Dec 16, 2024•over 1 year ago
Contract Type
partnership
Description
epiq Animal Health and Interpath Global have announced a strategic partnership to introduce 4CYTE™, a nutraceutical with a patented ingredient - Epiitalis®, to the animal health distribution channels in the United States. The product is scientifically proven to enhance joint health in dogs and horses, and has undergone rigorous assessments for safety and efficacy.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months